| Ganesh S Rao, MD | |
|
101 Hospital Blvd., Jeffersonville, IN 47130-3748 | |
| (812) 282-3899 | |
| (812) 282-4172 |
| Full Name | Ganesh S Rao |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 33 Years |
| Location | 101 Hospital Blvd., Jeffersonville, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104813161 | NPI | - | NPPES |
| 64031065 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 01053688A (Indiana) | Primary |
| 208800000X | Urology | 35247 (Kentucky) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Norton Hospitals, Inc | Louisville, KY | Hospital |
| Baptist Health Floyd | New albany, IN | Hospital |
| Physicians' Medical Center Llc | New albany, IN | Hospital |
| Clark Memorial Hospital | Jeffersonville, IN | Hospital |
| Jewish Hospital & St Mary's Healthcare | Louisville, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| First Urology Psc | 3779572888 | 47 |
| First Urology Psc | 3779572888 | 47 |
News Archive
An eating disorders research team led by Stephen Wonderlich, a Director of Clinical Research at the Neuropsychiatric Research Institute (NRI), has developed a successful bulimia nervosa therapy that can provide patients an alternative for treating this debilitating disorder.
According to data from a report released by the U.S. Centers for Disease Control and Prevention (CDC) in January 2004, only 35 percent of Virginia women of childbearing age take a vitamin pill that contains folic acid.
ALLOZYNE Inc. announced today the signing of a worldwide, co-exclusive licensing agreement with Sigma-Aldrich giving ALLOZYNE a license for the use of cycloaddition chemistry in the development of therapeutics and diagnostics. Sigma-Aldrich currently holds broad, worldwide intellectual property for the use of cycloaddition chemistry to conjugate biomolecules.
Immigration officials held a cancer patient for four hours before they allowed him to enter the USA because one of his cancer drugs caused his fingerprints to disappear. His oncologist is now advising all cancer patients who are being treated with the commonly used drug, capecitabine, to carry a doctor's letter with them if they want to travel to the USA.
Retinas from our earliest vertebrate ancestors had cone-like photoreceptors, presumably allowing them to see in daylight, but little ability to see at night. Then, millions of years ago in the Mesozoic era, and in relatively short order, mammals emerged that had retinas with predominantly rod photoreceptors, allowing for them to see at night perhaps to hunt for food while their dinosaur predators were dozing.
› Verified 2 days ago
| Entity Name | First Urology Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922099811 PECOS PAC ID: 3779572888 Enrollment ID: O20040512000212 |
News Archive
An eating disorders research team led by Stephen Wonderlich, a Director of Clinical Research at the Neuropsychiatric Research Institute (NRI), has developed a successful bulimia nervosa therapy that can provide patients an alternative for treating this debilitating disorder.
According to data from a report released by the U.S. Centers for Disease Control and Prevention (CDC) in January 2004, only 35 percent of Virginia women of childbearing age take a vitamin pill that contains folic acid.
ALLOZYNE Inc. announced today the signing of a worldwide, co-exclusive licensing agreement with Sigma-Aldrich giving ALLOZYNE a license for the use of cycloaddition chemistry in the development of therapeutics and diagnostics. Sigma-Aldrich currently holds broad, worldwide intellectual property for the use of cycloaddition chemistry to conjugate biomolecules.
Immigration officials held a cancer patient for four hours before they allowed him to enter the USA because one of his cancer drugs caused his fingerprints to disappear. His oncologist is now advising all cancer patients who are being treated with the commonly used drug, capecitabine, to carry a doctor's letter with them if they want to travel to the USA.
Retinas from our earliest vertebrate ancestors had cone-like photoreceptors, presumably allowing them to see in daylight, but little ability to see at night. Then, millions of years ago in the Mesozoic era, and in relatively short order, mammals emerged that had retinas with predominantly rod photoreceptors, allowing for them to see at night perhaps to hunt for food while their dinosaur predators were dozing.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ganesh S Rao, MD 101 Hospital Blvd., Jeffersonville, IN 47130-3748 Ph: (812) 282-3899 | Ganesh S Rao, MD 101 Hospital Blvd., Jeffersonville, IN 47130-3748 Ph: (812) 282-3899 |
News Archive
An eating disorders research team led by Stephen Wonderlich, a Director of Clinical Research at the Neuropsychiatric Research Institute (NRI), has developed a successful bulimia nervosa therapy that can provide patients an alternative for treating this debilitating disorder.
According to data from a report released by the U.S. Centers for Disease Control and Prevention (CDC) in January 2004, only 35 percent of Virginia women of childbearing age take a vitamin pill that contains folic acid.
ALLOZYNE Inc. announced today the signing of a worldwide, co-exclusive licensing agreement with Sigma-Aldrich giving ALLOZYNE a license for the use of cycloaddition chemistry in the development of therapeutics and diagnostics. Sigma-Aldrich currently holds broad, worldwide intellectual property for the use of cycloaddition chemistry to conjugate biomolecules.
Immigration officials held a cancer patient for four hours before they allowed him to enter the USA because one of his cancer drugs caused his fingerprints to disappear. His oncologist is now advising all cancer patients who are being treated with the commonly used drug, capecitabine, to carry a doctor's letter with them if they want to travel to the USA.
Retinas from our earliest vertebrate ancestors had cone-like photoreceptors, presumably allowing them to see in daylight, but little ability to see at night. Then, millions of years ago in the Mesozoic era, and in relatively short order, mammals emerged that had retinas with predominantly rod photoreceptors, allowing for them to see at night perhaps to hunt for food while their dinosaur predators were dozing.
› Verified 2 days ago
Aaron Blake Becker, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 101 Hospital Blvd, Jeffersonville, IN 47130 Phone: 812-282-3899 Fax: 812-282-4172 | |
Barry R Pecha, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 101 Hospital Blvd, Jeffersonville, IN 47130 Phone: 812-282-3899 Fax: 812-282-4173 | |
William Cooper Buschemeyer Jr., M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 101 Hospital Blvd, Jeffersonville, IN 47130 Phone: 812-282-3899 Fax: 812-282-4172 | |
Henry Nicholas Meiers, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 101 Hospital Blvd, Jeffersonville, IN 47130 Phone: 812-282-3899 Fax: 812-282-4172 | |
Christopher G Schrepferman, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 101 Hospital Blvd, Jeffersonville, IN 47130 Phone: 812-282-3899 Fax: 812-282-4172 | |
John H. Jurige Jr., M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 101 Hospital Blvd, Jeffersonville, IN 47130 Phone: 812-282-3899 Fax: 812-282-4172 |